Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer

被引：0
|
作者：
Renninson, Emily
Closier, Philippa
Jonnada, Sai
机构：
来源：
CLINICAL ONCOLOGY | 2018年 / 30卷
关键词：
D O I：
10.1016/j.clon.2018.07.025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [1] Incidence of febrile neutropenia in docetaxel chemotherapy without prophylactic granulocyte-colony stimulating factor (GCSF) for metastatic prostate cancer
    Renninson, Emily
    Closier, Philippa
    Jonnada, Sai
    [J]. CLINICAL ONCOLOGY, 2018, 30 : E4 - E4
  • [2] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Kimura, Yuri
    Sasada, Shinsuke
    Emi, Akiko
    Masumoto, Norio
    Kadoya, Takayuki
    Okada, Morihito
    [J]. SUPPORTIVE CARE IN CANCER, 2021, 29 (07) : 3507 - 3512
  • [3] Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer
    Yuri Kimura
    Shinsuke Sasada
    Akiko Emi
    Norio Masumoto
    Takayuki Kadoya
    Morihito Okada
    [J]. Supportive Care in Cancer, 2021, 29 : 3507 - 3512
  • [4] Prophylaxis of Febrile Neutropenia with granulocyte-colony stimulating factor
    Takamatsu, Yasushi
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 59 - 59
  • [5] Impact of granulocyte-colony stimulating factor on docetaxel-induced febrile neutropenia in patients with breast cancer
    Zekri, Jamal
    Nawaz, Azhar
    Rasool, Haleem
    Ahmad, Imran
    Abdel Rahman, Hossam
    Dada, Reyad
    Abdelghany, Ehab Mosaad
    Farag, Kamel
    Ibrahim, Refaei Belal
    Deibas, Mohamed Youssef
    Kamel, Mohamed Kamal
    Allithy, Ahmed
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1681 - 1686
  • [6] A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor (GCSF) on febrile neutropenia (FN) rates in (neo)adjuvant breast cancer chemotherapy regimens
    Zardawi, Sarah
    Zdenkowski, Nicholas
    Nordman, Ina
    Mallesara, Girish
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 190 - 191
  • [7] Real-world impact of granulocyte-colony stimulating factor on febrile neutropenia
    Altwairgi, A. K.
    Hopman, W. M.
    Mates, M.
    [J]. CURRENT ONCOLOGY, 2013, 20 (03) : E171 - E179
  • [8] THE CARDIOPROTECTIVE EFFECTS OF GRANULOCYTE-COLONY STIMULATING FACTOR (GCSF) IN PATIENTS RECEIVING ANTHRACYCLINE CHEMOTHERAPY
    Lahsaei, S.
    Le, D.
    Rahmani, S.
    Ren, H.
    Irwin, D.
    [J]. CARDIOLOGY, 2015, 131 : 235 - 235
  • [9] Granulocyte-colony stimulating factor for the prevention of chemotherapy-induced febrile neutropenia in the adult cancer patient population of Southern Israel
    Jacob Gilad
    Klaris Riesenberg
    Wilmosh Mermershtain
    Abraham Borer
    Avi Porath
    F. Schlaeffer
    [J]. Supportive Care in Cancer, 1999, 7 : 260 - 264
  • [10] Effects of primary granulocyte-colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with germ cell tumors
    Hapakova, Nikola
    Chovanec, Michal
    Rejlekova, Katarina
    Kalavska, Katarina
    Obertova, Jana
    Palacka, Patrik
    De Angelis, Valentina
    Svetlovska, Daniela
    Sycova-Mila, Zuzana
    Mardiak, Jozef
    Mego, Michal
    [J]. ONCOLOGY LETTERS, 2022, 24 (03)
12345